Evaluation of sample size and power for multi-arm survival trials allowing for non-uniform accrual, non-proportional hazards, loss to follow-up and cross-over
- 15 August 2006
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 25 (15) , 2521-2542
- https://doi.org/10.1002/sim.2517
Abstract
We present a general framework for sample size calculation in survival studies based on comparing two or more survival distributions using any one of a class of tests including the logrank test. Incorporated within this framework are the possible presence of non‐uniform staggered patient entry, non‐proportional hazards, loss to follow‐up and treatment changes including cross‐over between treatment arms. The framework is very general in nature and is based on using piecewise exponential distributions to model the survival distributions. We illustrate the use of the approach and explore its validity using simulation studies. These studies have shown that not adjusting for loss to follow‐up, non‐proportional hazards or cross‐over can lead to significant alterations in power or equivalently, a marked effect on sample size. The approach has been implemented in the freely available program ART (for Stata). Our investigations suggest that ART is the first software to allow incorporation of all these elements. Further extensions to the methodology such as non‐local alternatives for the logrank test are also considered. Copyright © 2006 John Wiley & Sons, Ltd.Keywords
This publication has 26 references indexed in Scilit:
- Sample size determination for comparing several survival curves with unequal allocationsStatistics in Medicine, 2004
- Novel designs for multi‐arm clinical trials with survival outcomes with an application in ovarian cancerStatistics in Medicine, 2003
- Sample size determination for comparing more than two survival distributionsStatistics in Medicine, 1995
- Power Calculations for Likelihood Ratio Tests in Generalized Linear ModelsPublished by JSTOR ,1992
- Sample sizes for proportional hazards survival studies with arbitrary patient entry and loss to follow‐up distributionsStatistics in Medicine, 1992
- A class of rank test procedures for censored survival dataBiometrika, 1982
- Sample size requirements for comparing time-to-failure among k treatment groupsJournal of Chronic Diseases, 1982
- Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observationJournal of Chronic Diseases, 1981